BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 31591636)

  • 1. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
    Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Raghavendra A; Sinha AK; Valle-Goffin J; Shen Y; Tripathy D; Barcenas CH
    Clin Breast Cancer; 2018 Feb; 18(1):e7-e13. PubMed ID: 29239836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
    PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
    Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
    Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
    Balazard F; Bertaut A; Bordet É; Mulard S; Blanc J; Briot N; Paux G; Dhaini Merimeche A; Rigal O; Coutant C; Fournier M; Jouannaud C; Soulie P; Lerebours F; Cottu PH; Tredan O; Vanlemmens L; Levy C; Mouret-Reynier MA; Campone M; Brady KJS; Sasane M; Rice M; Coulouvrat C; Martin AL; Jacquet A; Vaz-Luis I; Herold C; Pistilli B
    J Natl Cancer Inst; 2023 Sep; 115(9):1099-1108. PubMed ID: 37434306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital.
    Aldaak M; Suliman HM; Abd-Elgadir EE; Abdoon IH
    BMC Womens Health; 2022 Nov; 22(1):448. PubMed ID: 36376816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Health-Related Quality of Life among Breast Cancer Patients Receiving Different Plans of Treatment, Egypt.
    Mortada EM; Salem RA; Elseifi OS; Khalil OM
    J Community Health; 2018 Dec; 43(6):1183-1191. PubMed ID: 29876788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.
    Bargon CA; Batenburg MCT; van Stam LE; Mink van der Molen DR; van Dam IE; van der Leij F; Baas IO; Ernst MF; Maarse W; Vermulst N; Schoenmaeckers EJP; van Dalen T; Bijlsma RM; Young-Afat DA; Doeksen A; Verkooijen HM
    JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa104. PubMed ID: 33437925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population.
    Grasic Kuhar C; Gortnar Cepeda T; Kurzeder C; Vetter M
    Radiol Oncol; 2023 Jun; 57(2):211-219. PubMed ID: 37341200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy.
    Yang C; Li P; Chen Y; Zheng J; Zhang X; Gao HF; Zhang L; Wang K
    Support Care Cancer; 2024 Jun; 32(6):401. PubMed ID: 38829506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with breast cancer surgery and undergoing chemotherapy in Ahmednagar district.
    Kshirsagar AS; Wani SK
    J Cancer Res Ther; 2021; 17(6):1335-1338. PubMed ID: 34916362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Passildas J; Collard O; Savoye AM; Dohou J; Ginzac A; Thivat E; Durando X; Kwiatkowski F; Penault-Llorca F; Abrial C; Mouret-Reynier MA
    Clin Breast Cancer; 2019 Feb; 19(1):e74-e84. PubMed ID: 30448088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
    J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
    Yamamoto S; Masutani E; Arao H
    Breast Cancer; 2020 Jul; 27(4):670-682. PubMed ID: 32114664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes.
    Morgan JL; Shrestha A; Reed MWR; Herbert E; Bradburn M; Walters SJ; Martin C; Collins K; Ward S; Holmes G; Burton M; Lifford K; Edwards A; Ring A; Robinson T; Chater T; Pemberton K; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Thomson AM; Gosney M; Hatton M; Green T; Revill D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeschwar R; Wyld L
    Br J Surg; 2021 Apr; 108(3):315-325. PubMed ID: 33760065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
    Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
    Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.